tiprankstipranks
Trending News
More News >
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC
UK Market

Arecor Therapeutics PLC (AREC) Income Statement

Compare
4 Followers

Arecor Therapeutics PLC Income Statement

Last quarter (Q2 2025), Arecor Therapeutics PLC's total revenue was £2.00M, an increase of 20.01% from the same quarter last year. In Q2, Arecor Therapeutics PLC's net income was £-2.51M. See Arecor Therapeutics PLC’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 5.05M£ 4.57M£ 2.40M£ 1.16M£ 1.70M
Gross Profit
£ 1.54M£ 4.57M£ 2.40M£ 1.16M£ 1.70M
Operating Expenses
£ 12.24M£ 13.75M£ 12.91M£ 7.13M£ 5.13M
Depreciation and Amortization
£ 446.00K£ 496.00K£ 341.00K£ 171.00K£ 168.00K
EBITDA
£ -10.15M£ -8.39M£ -10.06M£ -6.27M£ -3.26M
Operating Income
£ -10.70M£ -9.18M£ -11.66M£ -5.98M£ -3.43M
Other Income/Expenses
£ 79.00K£ 274.00K£ 88.00K£ -506.00K£ -84.00K
Pretax Income
£ -10.62M£ -8.90M£ -10.54M£ -6.95M£ -3.51M
Net Income
£ -10.24M£ -8.55M£ -9.26M£ -6.17M£ -2.75M
Per Share Metrics
Basic EPS
£ -0.33£ -0.28£ -0.32£ -0.27£ -0.10
Diluted EPS
£ -0.33£ -0.28£ -0.32£ -0.27£ -0.10
Weighted Average Shares Outstanding
33.44M 30.62M 28.94M 23.03M 27.68M
Weighted Average Shares Outstanding (Diluted)
33.44M 30.62M 28.94M 23.03M 27.68M
Currency in GBP

Arecor Therapeutics PLC Earnings and Revenue History